MACROPHAGE INFLAMMATORY PROTEIN (MIP)-1-ALPHA STEM-CELL INHIBITOR (SCI) DOES NOT AFFECT CLONAL GROWTH OF HUMAN SOLID TUMOR-CELL LINES IN-VITRO
- A KORFEL
- Z VONMARSCHALL
- M KOENIGSMANN
- D OBERBERG
- B REUFI
- E THIEL
- WE BERDEL
Affiliations: FREE UNIV BERLIN,KLINIKUM STEGLITZ,DEPT HEMATOL & ONCOL,HINDENBURGDAMM 30,D-12200 BERLIN,GERMANY.
- Published online on: February 1, 1994 https://doi.org/10.3892/ijo.4.2.353
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
MIP-1alpha is a member of a family of proinflammatory cytokines produced by activated macrophages which has been shown to be a negative regulator of early hematopoietic stem cell progenitors. We report on results testing recombinant human (rh) MIP-1alpha on the clonal growth of different human nonhematopoietic tumor cell lines in vitro. Cell lines tested included the following histologies: 7 glioblastomas, 1 neuroblastoma, 2 head and neck carcinomas, 4 lung carcinomas, 3 colorectal carcinomas, 1 gastric carcinoma, 1 pancreatic carcinoma, 1 breast carcinoma, 1 prostate carcinoma, 1 choriocarcinoma, 1 ovary carcinoma, 1 osteosarcoma, and 3 melanomas. MIP-1alpha (0, 2, 20, 200 ng/ml) was tested in human tumor cloning assays (HTCA) in agar-containing capillaries (HTCAcap) and in mixtures of methylcellulose and agar (HTCAmix), representing assay systems with different plating efficiencies (PE). Tumor cells were continuously exposed to the cytokine for the complete assay period. Clonal growth of none of the cell lines was significantly and reproducibly stimulated or inhibited by MIP-1alpha.